HOME >> BIOLOGY >> NEWS
Key regulatory enzyme is a molecular 'octopus'

of constant stimulation," said Lefkowitz. "Years ago, we had discovered that this down-regulation occurs due to a phosphorylation of the activated receptor that triggers binding of a protein called beta arrestin. This protein stops further G protein signaling and acts as an adaptor and scaffolding that connects to other signaling molecules."

Thus, the cellular "stop signal" not only turns off the G protein, but immediately tags the receptor for recycling into the cell interior and turns on other signaling pathways, said Lefkowitz. His laboratory identified that enzyme as GRK, but a central mystery was how the family of GRK enzymes fulfills their intricate regulatory duties.

In the latest work the researchers deduced the structure of GRK2, the member of the GRK enzyme family that is active in heart muscle and many other tissues.

Critical to solving that mystery was obtaining the three-dimensional structure of GRK2 using X-ray crystallography. In this technique, pure crystals of a protein are bombarded by an intense X-ray beam, and the protein structure is deduced by analyzing the pattern of the beam's diffraction. This structural determination was done by co-author John Tesmer and his colleagues.

The resulting structure revealed the details of three regions, or domains, of the GRK2 enzyme, which had earlier been identified by biochemical studies in the Lefkowitz laboratory:

  • The central, or catalytic domain is the region that triggers the phosphorylation reaction
  • The "regulator of G protein signaling homology" (RH) domain attaches to the G protein to switch it off, and
  • The "PH" domain enables GRK2 to home in on the G protein at the cell membrane and attach to it.

To reveal how GRK2 interacts with the G protein, the researchers obtained the structure of GRK2 attached to a subunit of the G protein to which it normally binds, or complexes. Lefkowitz noted that a particularly striking achievem
'"/>

Contact: Dennis Meredith
dennis.meredith@duke.edu
919-681-8054
Duke University
19-Jun-2003


Page: 1 2 3

Related biology news :

1. Significant strides in small regulatory RNA research in plants
2. Pew report finds GM insects may offer benefits, but clear regulatory oversight is lacking
3. Researchers discover genes that control regulatory functions in malaria mosquitoes
4. Anthrax enzyme images reveal secrets of antibiotic resistance, suggest new drug design
5. First glimpse of DNA binding to viral enzyme
6. Two enzymes key to calorie-burning, Brown research shows
7. Argonne scientists determine structure of staph, anthrax enzyme
8. Brain serotonin enzyme finding might explain psychiatric disorders
9. Study finds plant enzyme function changes with location in cell
10. Basic RNA enzyme research promises single-molecule biosensors
11. Molecule that blocks key bacterial enzyme may lead to new antibiotics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol ... Capital Group, Inc., has been named to the elite "Forbes 30 ...  was one of 600 people in 20 fields nationwide to be ... of the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers ...
(Date:1/6/2017)... , Jan. 5, 2017  Delta ID Inc., ... iris scanning technology for automotive at CES® 2017. Delta ... GNTX ) to demonstrate the use of iris scanning ... and authenticate the driver in a car, and as ... the driving experience. Delta ID and Gentex ...
(Date:1/3/2017)... 2017 Onitor, provider of digital health technology ... an innovative biometric data-driven program designed to aid weight ... the 2017 Consumer Electronics Show (CES) in ... U.S., the World Health Organization (WHO), have identified lifestyle ... who are overweight or obese. WHO also states that ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, Inc. ... focused on the licensing, development and commercialization of innovative ... Best Company in North America ... the award based on the FDA approval of ... tablets), ENTYCE ® (capromorelin oral solution) and NOCITA ...
(Date:1/20/2017)... January 20, 2017 http://www.Financialbuzz.com ... one of leading causes of death worldwide. There were ... number of cancer related deaths increased gradually over time, ... incidence rate of various cancers continues to drive demand ... report by Global Market Insights, Inc. cancer biological therapy ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, ... open-access capability and technology platform, today announced that ... biology focused preclinical drug discovery contract research organization ... become a wholly-owned subsidiary of WuXi, and will ... and providing greater services. The acquisition will further ...
(Date:1/19/2017)... 2017  ArmaGen, Inc., today announced that it ... chief executive officer, as well as a member ... ArmaGen more than 17 years of executive management ... biotherapeutics and pharmaceuticals. "Mathias is ... and skillset necessary to lead ArmaGen to its ...
Breaking Biology Technology:
Cached News: